First-in-Class Drug Approved for Heavily Pretreated Myeloma

(MedPage Today) -- The FDA granted accelerated approval to talquetamab (Talvey) for treating adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, drug developer Janssen announced Thursday...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news